ETX — E-Therapeutics Share News
0.000.00%
Last trade - 00:00- £54.93m
- £23.53m
- £0.48m
Notice of AGM and Posting of Annual Report
Brief: e-therapeutics Raises £22.5 Mln
Results of conditional Fundraise to raise £22.5m
Retail Offer
Proposed Fundraise in excess of £20 million
Brief: E-Therapeutics FY Revenue 300,000 Stg
Final Results for the Year Ended 31 January 2021
Notification of Full Year Results Date
ETX to receive two payments from Galapagos
Brief: E-Therapeutics Says Karl Keegan Appointed CFO
Appointment of Chief Financial Officer
Brief: E-Therapeutics Says Trevor Jones To Assume New Role Of Non-Exec Chairman
Change of Adviser
Board Changes
Holding(s) in Company
e-therapeutics to present at Shares Evening
Holding(s) in Company
RNA Therapeutics Platform
Second Price Monitoring Extn